Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Pak J Pharm Sci ; 34(3(Supplementary)): 1097-1102, 2021 May.
Article de Anglais | MEDLINE | ID: mdl-34602438

RÉSUMÉ

Around fifteen percent women of reproductive age have been effected by Polycystic Ovarian Syndrome (PCOS); a complicated disorder; and apparently there is no standard therapy available. Considering this lack, we design present work; for the assessment of a herbal medicine (Femitex-SP4) in managing PCOs. During 2016-17; this study was carried out at Abbasi Shaheed hospital, Karachi, Pakistan. A total of 150 patients aged between 18-44 years were included as per Rotterdam criteria. Patients received 500 mg of powdered herbs in capsule form twice daily. The primary outcomes were regular menstruation and ovulation plus change in fasting blood sugar levels. Changes in free testosterone levels and ovarian morphology was secondary outcome measures. Continuous outcomes before and after treatment were compared by Student's t-test (one tailed, independent). P = 0.05 was considered as significant. Women menstrual cycle was considerably improved. Fasting blood sugar levels did not change (p=0.103392). Progesterone levels were same at the starting point and after treatment (P=0.318322). With complete recovery in 6 patients; a notable change was found in ovarian size. Free testosterone levels were also dropped significantly (p<0.00001). Our main success was drastic improvement in normalizing menstrual cycle during therapy. Herbal treatment is proven to be clinically effective in most of the patients; particularly PCOs patients with menstrual irregularities. Hence, Femitex-SP4 can be taken as a better treatment for PCOs.


Sujet(s)
Anovulation/physiopathologie , Glycémie/métabolisme , Theales , Fabaceae , Troubles de la menstruation/physiopathologie , Phyllanthus emblica , Syndrome des ovaires polykystiques/traitement médicamenteux , Vitex , Adulte , Femelle , Humains , Taille d'organe , Ovaire/anatomopathologie , Ovulation/physiologie , Phytothérapie , Syndrome des ovaires polykystiques/métabolisme , Syndrome des ovaires polykystiques/physiopathologie , Progestérone/métabolisme , Testostérone/métabolisme , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE